← Back to headlines
ImmunityBio Inc. Receives FDA Warning Letter Over Cancer Therapy Claims
ImmunityBio Inc. (IBRX) has received a warning letter from the FDA regarding claims made in an advertisement for its cancer therapy.
31 Mar, 15:06 — 31 Mar, 15:06
Sources
Showing 1 of 1 sources
